Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.54658 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.50455 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5047 | 21 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45395 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.44477 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.55947 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.56009 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.60514 | 27 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46651 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.48868 | 21 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.48594 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.46563 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.49489 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49457 | 21 |